Surgical Outcomes With Neoadjuvant Durvalumab Plus Chemotherapy Followed by Adjuvant Durvalumab in Resectable NSCLC.
- DOI
- 10.1016/j.jtho.2025.06.015
- Published
- 2025-06-20
- Container
- J Thorac Oncol
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jtho.2025.06.015,
title = {Surgical Outcomes With Neoadjuvant Durvalumab Plus Chemotherapy Followed by Adjuvant Durvalumab in Resectable NSCLC.},
author = {Mitsudomi T and Heymach JV and Reck M and Taube JM and Gao S and Horio Y and You J and Li G and Van Luong D and Saeteng S and Tanaka F and Watzka SB and Urban L and Szalai Z and Akamatsu H and Kang JH and Orlandi FJ and Mukhametshina GZ and Pircher A and Teixeira CHA and Aperghis M and Doherty GJ and Doake R and Fouad TM and Harpole D.},
year = {2025},
journal = {J Thorac Oncol},
doi = {10.1016/j.jtho.2025.06.015},
url = {https://doi.org/10.1016/j.jtho.2025.06.015}
}RIS
TY - JOUR TI - Surgical Outcomes With Neoadjuvant Durvalumab Plus Chemotherapy Followed by Adjuvant Durvalumab in Resectable NSCLC. AU - Mitsudomi T AU - Heymach JV AU - Reck M AU - Taube JM AU - Gao S AU - Horio Y AU - You J AU - Li G AU - Van Luong D AU - Saeteng S AU - Tanaka F AU - Watzka SB AU - Urban L AU - Szalai Z AU - Akamatsu H AU - Kang JH AU - Orlandi FJ AU - Mukhametshina GZ AU - Pircher A AU - Teixeira CHA AU - Aperghis M AU - Doherty GJ AU - Doake R AU - Fouad TM AU - Harpole D. PY - 2025 JO - J Thorac Oncol DO - 10.1016/j.jtho.2025.06.015 UR - https://doi.org/10.1016/j.jtho.2025.06.015 ER -
APA
T, M., JV, H., M, R., JM, T., S, G., Y, H., J, Y., G, L., D, V. L., S, S., F, T., SB, W., L, U., Z, S., H, A., JH, K., FJ, O., GZ, M., A, P., CHA, T., M, A., GJ, D., R, D., TM, F., & D., H. (2025). Surgical Outcomes With Neoadjuvant Durvalumab Plus Chemotherapy Followed by Adjuvant Durvalumab in Resectable NSCLC.. J Thorac Oncol. https://doi.org/10.1016/j.jtho.2025.06.015
Source records
- europe-pmc · retrieved 2026-09-27T12:22:26.776Z